Update of primary Helicobacter pylori resistance to antimicrobials in Brussels, Belgium.

Anti-Bacterial Agents / pharmacology Belgium / epidemiology Drug Resistance, Bacterial Gastric Mucosa / microbiology Helicobacter Infections / epidemiology Helicobacter pylori / drug effects Humans Microbial Sensitivity Tests
Antimicrobial resistance Clarithromycin Fluoroquinolones Helicobacter pylori Metronidazole

Journal

Diagnostic microbiology and infectious disease
ISSN: 1879-0070
Titre abrégé: Diagn Microbiol Infect Dis
Pays: United States
ID NLM: 8305899

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 02 04 2019
revised: 24 07 2019
accepted: 25 07 2019
pubmed: 3 9 2019
medline: 18 3 2020
entrez: 3 9 2019
Statut: ppublish

Résumé

This study aimed to follow the trend of primary antimicrobial resistance in Helicobacter pylori isolates obtained from several centers in Brussels. We observed increasing rates of primary resistance to macrolides (10.5% to 18%) to nitro-imidazoles (28% to 40%) and to fluoroquinolones (12.4% to 22.8%), respectively, from 2008/2009 to 2016.

Identifiants

DOI: 10.1016/j.diagmicrobio.2019.114875 PMID: 31474463
pubmed: 31474463
pii: S0732-8893(19)30351-7
doi: 10.1016/j.diagmicrobio.2019.114875
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

114875

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Veronique Yvette Miendje Deyi (VY)

Laboratoire Hospitalier Universitaire de Bruxelles, (LHUB-ULB) Department of Microbiology, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: veronique.miendjedeyi@lhub-ulb.be.

M'Kinansoi Sylvestre Lare (MS)

Ecole de Santé Publique, Université Libre de Bruxelles, Brussels, Belgium.

Alain Burette (A)

Gastroenterology Department, Centre HospitalierInter régional Edith Cavell, sites de la Basilique et E. Cavell, Brussels, Belgium.

Ruffin Ntounda (R)

Gastroenterology Unit, Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium.

Okyay Elkilic (O)

Gastroenterology Unit, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.

Samy Cadranel (S)

Gastroenterology-Hepatology Unit, Hôpital Universitaire des Enfants Reine Fabiola Université Libre de Bruxelles, Brussels, Belgium.

Patrick Bontems (P)

Gastroenterology-Hepatology Unit, Hôpital Universitaire des Enfants Reine Fabiola Université Libre de Bruxelles, Brussels, Belgium.

Marie Hallin (M)

Laboratoire Hospitalier Universitaire de Bruxelles, (LHUB-ULB) Department of Microbiology, Université Libre de Bruxelles, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Update of primary Helicobacter pylori...
questionsmedicales.fr › Régions géographiques › Europe › Belgique › Update of primary Helicobacter pylori...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance bactérienne aux médicaments › Update of primary Helicobacter pylori...
questionsmedicales.fr › Tissus › Membranes › Muqueuse › Muqueuse gastrique › Update of primary Helicobacter pylori...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Helicobacter › Update of primary Helicobacter pylori...
questionsmedicales.fr › Bactéries › Proteobacteria › Epsilonproteobacteria › Campylobacterales › Helicobacteraceae › Helicobacter › Helicobacter pylori › Update of primary Helicobacter pylori...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Update of primary Helicobacter pylori...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Update of primary Helicobacter pylori...